{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2021/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Edoardo Burini", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ed_ln:burini-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
EB

Edoardo Burini — 2 Patents in 2021

Merck: 2 patents #121 of 909Top 15%
Guidonia, IT: #2 of 3 inventorsTop 70%
Overall (2021): #165,127 of 548,734Top 35%
2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11103512 Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol Michael Lange, Clemens Kuehn, Thomas Fuchss, David Maillard, Marcel Breuning +1 more 2021-08-31 $154,425,000
11053233 Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol Michael Lange, Clemens Kuehn, Thomas Fuchss, David Maillard, Marcel Breuning +1 more 2021-07-06 $119,175,000